AlphaMark Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

AlphaMark Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-42,651	Closed	-$700K	–	316
2015 Q3	$700K	Hold	42,651	–	–	0.39%	59
2015 Q2	$973K	Sell	42,651 -67,705	-61%	-$1.35M	0.55%	46
2015 Q1	$1.68M	Buy	110,356 +47	+0%	+$611	0.94%	39
2014 Q4	$1.33M	Sell	110,309 -20,390	-16%	-$233K	0.82%	38
2014 Q3	$1.48M	Buy	130,699 +1,985	+2%	+$22.6K	0.94%	37
2014 Q2	$1.55M	Buy	128,714 +66,714	+108%	+$788K	0.93%	37
2014 Q1	$722K	Buy	+62,000	New	+$1.05M	0.44%	48

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AlphaMark Advisors's MNTA Position: Q4 2015 in Review

AlphaMark Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 42,651 shares — an estimated $700K sold.

AlphaMark Advisors first reported a position in MNTA in Q1 2014 and held it in 7 quarters. The position peaked at $1.68M in Q1 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

AlphaMark Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
AlphaMark Advisors sold 42,651 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $700K.
AlphaMark Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
AlphaMark Advisors's Momenta Pharmaceuticals, Inc. position peaked at $1.68M in Q1 2015.
164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on AlphaMark Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.